Application 090526
- Type
- ANDA
- Sponsor
- BARR LABS DIV TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXYBUTYNIN | OXYBUTYNIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 3.9MG/24HR | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090526-001 | OXYBUTYNIN | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A090526-001 | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2014-03-04 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| oxybutynin | OXYBUTYNIN | Zydus Lifesciences Limited | f405a774-bd91-4513-b7c7-c44f0596d988 | 2024-12-03 | oxybutynin OXYBUTYNIN | |
| oxybutynin | OXYBUTYNIN | NCS HealthCare of KY, LLC dba Vangard Labs | ec4fd95f-16dc-4acf-b560-b67b7aaef08b | 2024-09-13 | Warnings, Adverse reactions | oxybutynin OXYBUTYNIN |
| Oxytrol for Women | OXYBUTYNIN | Allergan, Inc. | 8cdc5b4d-ff8d-4010-97d7-313422a0b868 | 2024-08-15 | Warnings | OXYBUTYNIN |
| oxybutynin | OXYBUTYNIN | NCS HealthCare of KY, LLC dba Vangard Labs | ed10f0c9-23d6-4ded-b17f-ed474632a965 | 2024-08-12 | Warnings, Adverse reactions | oxybutynin OXYBUTYNIN |
| OXYTROL | OXYBUTYNIN | Allergan, Inc. | 20dee37f-1412-44ed-9e8b-f4379ce23eb0 | 2024-05-29 | Warnings, Adverse reactions | OXYBUTYNIN |
| oxybutynin | OXYBUTYNIN | Zydus Pharmaceuticals USA Inc. | c042bf06-79a3-4dc7-ae05-3ef3cfae9d44 | 2023-11-07 | Warnings, Adverse reactions | oxybutynin OXYBUTYNIN |
| oxybutynin | OXYBUTYNIN | A-S Medication Solutions | 1f95920c-5dc2-44e4-b61d-b2c5e05390ba | 2023-02-06 | Warnings, Adverse reactions | oxybutynin OXYBUTYNIN |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9272 | ORIG | 2014-03-06 |